| 12049465 |
Tricyclic compounds and their use as phosphodiesterase inhibitors |
Thomas Allen Chappie, Nandini Chaturbhai Patel, Patrick Robert Verhoest, Christopher John Helal, Erik Alphie LaChapelle +2 more |
2024-07-30 |
$542,147,000 |
| 11472805 |
Tricyclic compounds and their use as phosphodiesterase inhibitors |
Thomas Allen Chappie, Nandini Chaturbhai Patel, Patrick Robert Verhoest, Christopher John Helal, Erik Alphie LaChapelle +2 more |
2022-10-18 |
$393,425,000 |
| 11390623 |
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands |
Thomas Allen Chappie, Jaclyn Louise Henderson, Joseph Michael Young, Travis T. Wager, Bethany Lyn Kormos +4 more |
2022-07-19 |
$2,227,040,000 |
| 10966980 |
Pyrrolo[2,3-d]pyrimidine derivatives |
Michael L. Vazquez, Neelu Kaila, Jamison B. Tuttle, Patrick Robert Verhoest, Matthew Richard Reese +4 more |
2021-04-06 |
$415,547,000 |
| 10738063 |
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds |
Thomas Allen Chappie, Nandini Chaturbhai Patel, Patrick Robert Verhoest, Christopher John Helal, Erik Alphie LaChapelle +2 more |
2020-08-11 |
$655,725,000 |
| 10669279 |
Imidazopyridazine compounds |
Thomas Allen Chappie, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal, Erik Alphie LaChapelle +2 more |
2020-06-02 |
$395,652,000 |
| 10590128 |
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands |
Thomas Allen Chappie, Jaclyn Louise Henderson, Joseph Michael Young, Travis T. Wager, Bethany Lyn Kormos +4 more |
2020-03-17 |
$194,251,000 |
| 10323042 |
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds |
Thomas Allen Chappie, Nandini Chaturbhai Patel, Patrick Robert Verhoest, Christopher John Helal, Erik Alphie LaChapelle +2 more |
2019-06-18 |
$923,940,000 |
| 10131669 |
Pyrazolopyrimidine compounds |
Thomas Allen Chappie, Patrick Robert Verhoest, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal +3 more |
2018-11-20 |
$851,493,000 |
| 10077269 |
Imidazopyridazine compounds |
Thomas Allen Chappie, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal, Erik Alphie LaChapelle +2 more |
2018-09-18 |
$396,134,000 |
| 9598421 |
Imidazopyridazine compounds |
Thomas Allen Chappie, Patrick Robert Verhoest, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal +2 more |
2017-03-21 |
$801,098,000 |
